Registration No.:	22PIP632
Name:	Lakshmi Mounika Kelam
Ph.D. Thesis Title:
Connect at:	Linkedin
Research: 2
Bhagat A, Kelam LM, Samanta N, Sobhia ME. Structure-guided design and triplicate molecular dynamics evaluation of mutant peptide inhibitors targeting SARS-CoV-2 main protease (Mpro). In Silico Pharmacology 2025, 13: 125.
Kelam LM, Gill MS, Sobhia ME. Revolutionizing diabetes treatment: computational insights into 4-hydroxy isoleucine derivatives and advanced molecular screening for antidiabetic compounds. Exploration of Drug Science 2025, 3: 1008104.
Review: 1
Kelam LM, Chhabra V, Dhiman S, Kumari D, Sobhia ME. Protein tyrosine phosphatase inhibitors: a patent review and update (2012-2023). Expert Opinion on Therapeutic Patents 2024, 34: 187-209.
Books/Book Chapters: 0